Ubs Asset Management Americas Inc Repligen Corp Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Repligen Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 252,497 shares of RGEN stock, worth $32.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
252,497
Previous 235,343
7.29%
Holding current value
$32.2 Million
Previous $33.9 Million
5.16%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$965 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$964 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$648 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$215 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$213 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.07B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....